| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Revenue | $1.44B | -4.9% |
| Cost of Revenue | $812.7M | -1.9% |
| Gross Profit | $630.5M | -8.5% |
| R&D Expense | $280.0M | -8.1% |
| SG&A Expense | $119.8M | -15.8% |
| Operating Income | -$50.5M | -5.0% |
| Pre-tax Income | -$50.5M | -86.0% |
| Income Tax | $10.6M | -3.2% |
| Net Income | -$61.1M |
| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $174.7M | +2.9% |
| Accounts Receivable | $65.8M | +47.9% |
| Inventory | $171.0M | -26.1% |
| Current Assets | $504.0M | -8.5% |
| Total Assets | $823.3M | -10.2% |
| Current Liabilities | $352.4M | -3.8% |
| Total Liabilities | $468.1M | -4.0% |
| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $136.9M | -27.9% |
| Investing Cash Flow | -$29.5M | +72.0% |
| Financing Cash Flow | -$102.3M | +25.5% |
| -60.3% |
| EPS (Basic) | -$0.51 | -64.5% |
| EPS (Diluted) | -$0.51 | -64.5% |
| Stockholders' Equity |
| $355.2M |
| -17.1% |